RECOMBINANT AVIAN PARAMYXOVIRUS VACCINE AND METHOD FOR MAKING AND USING THE SAME

Japanese Patent JP2016041079

A

PROBLEM TO BE SOLVED: To provide a vector vaccine platform which can provide the basis for safe vaccines for expression of heterologous antigens.SOLUTION: The present invention encompasses engineered APMV compositions or vaccines. The vaccines or compositions may be recombinant APMV compositions or vaccines. The present invention encompasses: methods for modifying the genome of APMV to produce recombinant APMV; modified APMV prepared by such methods; DNA and protein sequences; and methods for infecting cells and hosts with such recombinant APMV.SELECTED DRAWING: Figure 19A

WO/2002/000715	MAMMAL 2P DOMAIN MECHANO-SENSITIVE K?+¿ CHANNEL, CLONING AND APPLICATIONS THEREOF
JP2004113099	METHOD FOR EFFICIENTLY TRANSFECTING CELL WITH POLYNUCLEOTIDE USING TRANSFECTING REAGENT
JP2020188816	METHODS AND COMPOSITIONS FOR PREDICTING ENZASTAURIN ACTIVITY

MICHEL BUBLOT
TESHOME MEBATSION
JOYCE PRITCHARD
EGBERT MUNDT

JP2015246684A

March 31, 2016

December 17, 2015

Click for automatic bibliography generation  

MERIAL LTD
UNIV OF GEORGIA RES FOUNDATION INC

C12N15/09; A61K39/00; C12N7/01

JP2002272465A

2002-09-24

ANANDAN PALDURAI, ET AL.: "Complete genome sequences of avian paramyxovirus type 8 strains goose/Delaware/1053/76 and pintail/W", VIRUS RES., vol. 142, JPN6014036983, June 2009 (2009-06-01), pages 144 - 53, XP026083824, ISSN: 0003466169, DOI: 10.1016/j.virusres.2009.02.003
"Definition: Avian paramyxovirus 8 strain goose/Delaware/1053/76, complete genome.", DATABASE NUCLEOTIDE, [ONLINE], GENBANK ACCESSION NO. FJ215863.1, JPN6016047727, 22 July 2009 (2009-07-22), ISSN: 0003466170

Takaki Nishijima
Disciple Maru Ken
Shinichiro Tanaka
Atsushi Hakoda
Kenji Asai
Kazuo Yamazaki
Satsuki Ichikawa
Takamitsu Hoshino

Previous Patent: MUTATIONS OF PIK3CA GENE IN HUMAN CANCERS

Next Patent: NUCLEIC ACID COMPRISING OR ENCODING HISTONE STEM LOOP AND POLY(A) SEQUENCE OR POLYADENYLATION SIGNAL...